Organon (OGN) Payables (2020 - 2026)

Organon (OGN) has reported Payables for 7 consecutive years, with $983.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Payables fell 2.29% year-over-year to $983.0 million; the TTM figure through Mar 2026 stood at $983.0 million (down 2.29% YoY), while the FY2025 annual figure was $952.0 million, down 17.43% from the prior year.
• Payables came in at $983.0 million for Q1 2026 at Organon, up from $952.0 million in the prior quarter.
• The five-year high for Payables was $1.3 billion in Q4 2023, with the low at $952.0 million in Q4 2025.
• Average Payables over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2025.
• The largest YoY upside for Payables was 309.47% in 2022 against a maximum downside of 38.55% in 2022.
• Year by year, Payables stood at $1.1 billion in 2022, then rose by 16.08% to $1.3 billion in 2023, then dropped by 12.25% to $1.2 billion in 2024, then slipped by 17.43% to $952.0 million in 2025, then gained by 3.26% to $983.0 million in 2026.
• According to Business Quant data, Payables over the past three periods registered $983.0 million, $952.0 million, and $1.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.